Biome Grow Inc. (“Biome” or the “Company”) (CSE:BIO, OTCQB:BIOIF, 6OTA:GR) today released consolidated financial statements for the second quarter and first half of fiscal 2019. The unaudited interim consolidated financial statements including the notes thereto, the Company’s corresponding Management’s Discussion and Analysis and a supplemental information presentation are available on the Company’s website at www.biomegrow.com under “investors” and on SEDAR at www.SEDAR.COM. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
Highlights of the Quarter:
- Revenue in Q2 was approximately four times the level realized in Q1: $1.35MM vs $341M. Gross profit approximately tripled over the same period: $600M versus $204M.
- Average selling price per gram increased by 15% from $6.80 to $7.86 while the average cost per gram of our cultivated product declined to $2.31 from $2.72 sequentially.
- Highland Grow was net income profitable in Q2 on a stand-alone basis, a significant achievement for an operation in only its second quarter of commercial production.
- Biome received approval to sell cannabis in the province of Saskatchewan.
Subsequent to the quarter, there were three other positive developments which we feel bode well for Q3:
- Biome introduced new packaging automation in its facility in Antigonish, Nova Scotia that will greatly increase the amount of product Highland Grow can supply its customers with.
- Earlier this month, Biome announced that it had increased its national supply footprint to five provinces from three adding Manitoba and a supply agreement with the provincial government of New Brunswick
- Also, in August, Biome received Environmental Approval for the refurbishment of its flagship facility in Newfoundland and Labrador.
Biome CEO Khurram Malik: “We’re very proud of the work our Highland Grow team in Nova Scotia has done to achieve a significant sequential ramp up in business in the second quarter. We are also very proud that Highland Grow was able to achieve profitability less than two quarters after entering commercial production. This aligns with our stated vision from the start to build strong, local brands with products that end customers feel are designed specifically for their unique requirements.
Our current quarter (Q3), is also achieving a significant increase in business over what we are reporting today for Q2 and we are looking forward to sharing these results once this period has concluded.”
A live audio webcast will be available at
Toll Free Dial-In Number: 1 (866) 211 3199
International Dial-In Number (647) 689 6601
Conference ID 2961839
For further information, please contact:
VP Investor Relations
Kellie Coppin Renmark Financial
Biome wholly owns five subsidiaries, including: The Back Home Medical Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the Cannabis Act; Great Lakes Cannabis, a company incorporated under the laws of the Province of Ontario and in the late stages of applying for a license under the Cannabis Act; Highland Grow Inc., a licensed producer in Nova Scotia under Canada’s ACMPR; Red Sands Craft Cannabis Co., a company incorporated under the laws of the Province of Prince Edward Island, and; Weed Virtual Retail Inc., a company incorporated under the laws of the Province of Ontario in the business of operating a new virtual reality technology platform focused exclusively on the medical and recreational cannabis markets. Biome is a Canadian-based company with national and international business interests.
This news release contains forward-looking statements and forward-looking information within the meaning of applicable Canadian securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “ expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning statements with respect to sales and positioning, supply and demand, and the potential growth of the Company, including the new packaging automation. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to Biome, including, among other things, assumptions and expectations with respect to general economic conditions, the expected timing and cost associated with the Company’s plans, future growth of the Company’s business, the development of new products and product formats, the Company’s ability to retain key personnel, the Company’s ability to continue investing in its infrastructure to support growth, the impact of competition, trends in the Canadian cannabis industry and changes in laws, rules and regulations. The forward-looking information contained in this news release is subject to known and unknown risks and uncertainties, including but not limited to, adverse economic, regulatory and/or legislative developments, delays with respect to the Company’s plans and those risks and uncertainties described in the Company’s management’s discussion and analysis and in the Company’s annual information form (both of which are available electronically at www.sedar.com), any of which could cause actual results to differ materially from those expressed or implied by the forward-looking information disclosed herein. Accordingly, readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements speak only as of the date on which they are made, and Biome, or any of its subsidiaries undertakes no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Future Oriented Financial Information and Financial Outlook
To the extent any forward-looking information in this news release constitutes future-oriented financial information or financial outlook, within the meaning of applicable securities laws (collectively, “FOFI”), such information is being provided to demonstrate the potential of the Company and readers are cautioned that this information may not be appropriate for any other purpose. The FOFI is subject to the same assumptions, risk factors, limitations, and qualifications asset forth in the above paragraphs, in addition to assumptions with respect to the prices to be paid for the Company’s products, the costs and expenditures to be incurred by the Company and the costs associated with production and related projects. FOFI contained in this news release was made as of the date of this news release and was provided by management for the purpose of providing further information about Biome’s future business operations. The Company believes that the FOFI has been prepared on a reasonable basis, reflecting management’s best estimates and judgments. However, because this information is highly subjective and subject to numerous risks including the risks discussed herein and above, it should not be relied on as necessarily indicative of future results. The actual results of operations of the Company and the resulting financial results may vary from the amounts set forth herein, and such variations may be material. Biome disclaims any intention or obligation to update or revise any FOFI contained in this news release, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Investors are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein.
Find out what experts say about profiting from the cannabis market in 2021!
Read our FREE 2021 cannabis outlook report!
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).